Federal health officials announced Monday they are giving pharmaceutical companies extra time to enroll in a groundbreaking program designed to bring down prescription drug costs for Americans receiving Medicaid benefits.
The Centers for Medicare & Medicaid Services has moved the application deadline from March 31 to April 30, 2026, for drug manufacturers interested in participating in the new payment structure.
The initiative aims to reduce medication expenses within the Medicaid system, which serves low-income individuals and families, bringing those costs in line with what other developed countries pay for prescription drugs.
